[1] [2] The most frequently reported side effects in clinical trials were gastrointestinal in nature, including nausea (occurring in up to 44% of patients taking Wegovy at the 2.4 mg dose), vomiting, diarrhea, abdominal pain, and constipation
The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes
How GLP-1/GIP dual agonists work for weight loss GLP-1/GIP dual agonists (or "co-agonists") mimic the actions of two peptide hormones, GLP-1 and GIP
In Drug Channels Institute, an HMP Global Company, MMITs Sean Wagner and Carolyn Zele share the top six market research tasks to complete in Phases II and III
Learning how to give yourself a subcutaneous (SubQ) injection can feel intimidating at first, but with proper preparation and guidance from your provider, it can become a straightforward part of your wellness routine
When tested in musk shrews (a species that, unlike rodents, can vomit), TDN reduced weight without triggering emesis, while exendin-4 caused rapid, dose-dependent vomiting